Skip to content

BBNX BBNX Total debt

Total debt at other companies

Insulet logo
InsuletPODD
$969.7M-45.5%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$734.74M+49.0%
AdaptHealth logo
AdaptHealthAHCO
$2B-4.9%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$2.18B+41.7%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $6.91M.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's total debt?
BBNX (BBNX) reported total debt of $6.91M in Q1 2026.
How has BBNX's total debt changed year-over-year?
BBNX's total debt decreased by 0.9% year-over-year, from $6.97M to $6.91M.
What is the long-term trend for BBNX's total debt?
Over 2 years (2023 to 2025), BBNX's total debt has grown at a 31.5% compound annual growth rate (CAGR), from $4.22M to $7.3M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.